In this article, I will show you how you could allocate $10,000 among my top 20 dividend growth and high dividend yield companies for the month of April. Due to the allocation I have chosen, that I'll
In today's article, I will present you with my top 10 dividend growth stocks to invest in for April 2023. The selected picks are all financially strong, have a relatively low Payout Ratio, an attracti
Gina Sanchez, chief market strategist at Lido Advisors, and Chad Morganlander, senior portfolio manager with Washington Crossing Advisors, joins 'The Exchange' to discuss defensive but expensive divid

2 Top Stocks to Buy in April and Hold Forever

07:39am, Saturday, 08'th Apr 2023
Bristol Myers Squibb and Stryker are both developing life-changing products for patients. The two companies each pay growing dividends to shareholders.
I'm reviewing my February and March results in this piece. My passive income stream grew by 22.63% in February and by 46.87% in March.
Label expansion of Bristol Myers' (BMY) new drugs should help it somewhat combat the decline in Revlimid sales due to generic competition.

My Dividend Growth Portfolio - Q1 2023 Summary

01:26am, Thursday, 06'th Apr 2023
In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. This is part of being transparent with my readers, so they can see what I hold and its
Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

2 Ultra-Cheap Dividend Stocks to Buy in April

11:00am, Tuesday, 04'th Apr 2023
These two big pharma stocks are trading at steep discounts.
Bristol Myers (BMY) receives a positive CHMP opinion for CAR T cell therapy with Breyanzi for relapsed or refractory large B-cell lymphoma after one prior treatment.
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.

4 Dividend Stocks To Buy In April 2023

07:36am, Friday, 31'st Mar 2023
All 4 of these stocks are trading at a discount to their historical average. These companies have the ability to outperform regardless of the economic backdrop.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Bristol Myers' (BMY) Sotyktu gets approval from the European Commission to treat adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy.
Big pharma stocks ought to perform well in the current high interest rate environment. Eli Lilly and Bristol Myers Squibb have long been top value plays.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE